Takip et
Skye Fishbein
Skye Fishbein
Postdoctoral Researcher at Washington University in St. Louis
wustl.edu üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Phylogeny to function: PE/PPE protein evolution and impact on Mycobacterium tuberculosis pathogenicity
S Fishbein, N Van Wyk, RM Warren, SL Sampson
Molecular microbiology 96 (5), 901-916, 2015
2432015
Antibiotic perturbations to the gut microbiome
SRS Fishbein, B Mahmud, G Dantas
Nature Reviews Microbiology 21 (12), 772-788, 2023
1482023
Genetically stable CRISPR-based kill switches for engineered microbes
AG Rottinghaus, A Ferreiro, SRS Fishbein, G Dantas, TS Moon
Nature communications 13 (1), 672, 2022
1222022
Ribosomal mutations promote the evolution of antibiotic resistance in a multidrug environment
JE Gomez, BB Kaufmann-Malaga, CN Wivagg, PB Kim, MR Silvis, ...
Elife 6, e20420, 2017
822017
Antimicrobial resistance in enteric bacteria: current state and next-generation solutions
MJ Wallace, SRS Fishbein, G Dantas
Gut microbes 12 (1), 1799654, 2020
802020
Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis
SRS Fishbein, JI Robinson, T Hink, KA Reske, EP Newcomer, ...
Elife 11, e72801, 2022
312022
Randomized controlled trial of oral vancomycin treatment in Clostridioides difficile-colonized patients
SRS Fishbein, T Hink, KA Reske, C Cass, E Struttmann, ZH Iqbal, S Seiler, ...
MSphere 6 (1), 10.1128/msphere. 00936-20, 2021
292021
Randomized controlled trial of oral vancomycin treatment in
SRS Fishbein, T Hink, KA Reske, C Cass, E Struttmann, ZH Iqbal, S Seiler, ...
Clostridioides difficile, 00936-20, 2021
122021
The conserved translation factor LepA is required for optimal synthesis of a porin family in Mycobacterium smegmatis
SRS Fishbein, FG Tomasi, ID Wolf, CL Dulberger, A Wang, H Keshishian, ...
Journal of bacteriology 203 (6), 10.1128/jb. 00604-20, 2021
82021
Clinical sequelae of gut microbiome development and disruption in hospitalized preterm infants
R Thänert, DJ Schwartz, EC Keen, C Hall-Moore, B Wang, N Shaikh, ...
Cell host & microbe 32 (10), 1822-1837. e5, 2024
42024
Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation
JH Choi, EC Keen, MA Wallace, S Fishbein, J Prusa, M Zimbric, ...
The Journal of Infectious Diseases 228 (3), 321-331, 2023
32023
Reagents for improving PCR accuracy
J Rice, L Wangh, AH Reis, K Pierce, C Hartshorn, JA Sanchez, ...
US Patent 10,301,688, 2019
32019
A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden
ON Rebeck, MJ Wallace, J Prusa, J Ning, EM Evbuomwan, S Rengarajan, ...
Cell Chemical Biology 32 (1), 98-110. e7, 2025
22025
Multi-omics investigation of Clostridioides difficile-colonized patients reveals protective commensal carbohydrate metabolism
SRS Fishbein, JI Robinson, T Hink, KA Reske, EP Newcomer, ...
bioRxiv, 2021.08. 24.457492, 2021
22021
Conquering homocystinuria with engineered probiotics
SRS Fishbein, EM Evbuomwan, G Dantas
Cell Host & Microbe 32 (3), 298-300, 2024
12024
Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting
EP Newcomer, SRS Fishbein, K Zhang, T Hink, KA Reske, C Cass, ...
Mbio 15 (3), e03300-23, 2024
12024
Draft genome sequence of a Mycobacterium strain isolated from a clinical wound sample
EM Ransom, SS Sawhney, G Dantas, CAD Burnham, SRS Fishbein
Microbiology Resource Announcements 11 (7), e00170-22, 2022
12022
A conserved translation factor is required for optimal synthesis of a membrane protein family in mycobacteria
SRS Fishbein, ID Wolf, CL Dulberger, A Wang, H Keshishian, L Wallace, ...
bioRxiv, 872341, 2019
12019
The tetracycline resistome is shaped by selection for specific resistance mechanisms by each antibiotic generation
KS Blake, YP Xue, VJ Gillespie, SRS Fishbein, NH Tolia, TA Wencewicz, ...
Nature Communications 16 (1), 1452, 2025
2025
A yeast-based oral therapeutic delivers immune checkpoint inhibitors to reduce intestinal tumor burden
S Rengarajan, LM Habimana-Griffin, S Kwak, D Zahrah, J Tung, J Liao, ...
Cell Chemical Biology 32, 1-13, 2025
2025
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20